72 related articles for article (PubMed ID: 35244188)
1. Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A).
Adayev T; Wegiel J; Hwang YW
Arch Biochem Biophys; 2011 Mar; 507(2):212-8. PubMed ID: 21185805
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
[TBL] [Abstract][Full Text] [Related]
3. Lactiplantibacillus plantarum K8 lysates regulate hypoxia-induced gene expression.
Jeong J; Kang BH; Ju S; Park NY; Kim D; Dinh NTB; Lee J; Rhee CY; Cho DH; Kim H; Chung DK; Bunch H
Sci Rep; 2024 Mar; 14(1):6275. PubMed ID: 38491188
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induces tumor cell growth and angiogenesis in non-small cell lung carcinoma via the Akt-PDK1-HIF1α-YKL-40 pathway.
Miao Y; Wang W; Dong Y; Hu J; Wei K; Yang S; Lai X; Tang H
Transl Cancer Res; 2020 Apr; 9(4):2904-2918. PubMed ID: 35117647
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Erythroid Differentiation via the HIF1α-NFIL3-PIM1 Signaling Axis Under Hypoxia.
Yu HC; Cui R; Chen MY; Du XY; Bai QR; Zhang SL; Guo JJ; Tong FC; Wu J
Antioxid Redox Signal; 2024 Apr; ():. PubMed ID: 38573002
[No Abstract] [Full Text] [Related]
6. Interleukin-17 governs hypoxic adaptation of injured epithelium.
Konieczny P; Xing Y; Sidhu I; Subudhi I; Mansfield KP; Hsieh B; Biancur DE; Larsen SB; Cammer M; Li D; Landén NX; Loomis C; Heguy A; Tikhonova AN; Tsirigos A; Naik S
Science; 2022 Jul; 377(6602):eabg9302. PubMed ID: 35709248
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1α in myocardial infarction.
Škrlec I; Kolomeichuk SN
World J Cardiol; 2024 Apr; 16(4):181-185. PubMed ID: 38690212
[TBL] [Abstract][Full Text] [Related]
8. Select DYRK1A Inhibitors Enhance Both Proliferation and Differentiation in Human Pancreatic Beta Cells.
Wang P; Wood O; Choleva L; Liu H; Karakose E; Lambertini L; Pillard A; Wu V; Garcia-Ocana A; Scott DK; Kumar K; DeVita RJ; Stewart AF
bioRxiv; 2024 May; ():. PubMed ID: 38798411
[TBL] [Abstract][Full Text] [Related]
9. Data supporting a pilot high-throughput screen of a drug library for identification of DYRK1A inhibitors and high-content imaging analysis of identified harmine analogs.
Tarpley M; Oladapo H; Caligan TB; Onyenwoke RU; Williams KP
Data Brief; 2021 Aug; 37():107189. PubMed ID: 34141844
[TBL] [Abstract][Full Text] [Related]
10. HIF1α-glycolysis engages activation-induced cell death to drive IFN-γ induction in hypoxic T cells.
Shen H; Mullen L; Ojo OA; Xing C; Yassin A; Lewis Z; Bonner JA; Shi LZ
Res Sq; 2024 Jan; ():. PubMed ID: 38260594
[TBL] [Abstract][Full Text] [Related]
11. USP38 promotes deubiquitination of K11-linked polyubiquitination of HIF1α at Lys769 to enhance hypoxia signaling.
Wang R; Cai X; Li X; Li J; Liu X; Wang J; Xiao W
J Biol Chem; 2024 Jan; 300(1):105532. PubMed ID: 38072059
[TBL] [Abstract][Full Text] [Related]
12. Oxygen and HIF1α-dependent SDF1 expression in primary astrocytes.
Pietrucha A; Serdar M; Bendix I; Endesfelder S; Brinke EAD; Urkola A; Bührer C; Schmitz T; Scheuer T
Dev Neurobiol; 2024 Mar; ():. PubMed ID: 38544386
[TBL] [Abstract][Full Text] [Related]
13. Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs.
Laham AJ; El-Awady R; Ayad MS; Wang N; Yan G; Boudreault J; Ali S; Lebrun JJ
NPJ Precis Oncol; 2024 Jun; 8(1):128. PubMed ID: 38839871
[TBL] [Abstract][Full Text] [Related]
14. DYRK1A reinforces epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma via cooperatively activating STAT3 and SMAD.
Li YL; Zhang MM; Wu LW; Liu YH; Zhang ZY; Zeng LH; Lin NM; Zhang C
J Biomed Sci; 2022 Jun; 29(1):34. PubMed ID: 35655269
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-221-3p inhibits the inflammatory response of keratinocytes by regulating the DYRK1A/STAT3 signaling pathway to promote wound healing in diabetes.
Hu K; Liu L; Tang S; Zhang X; Chang H; Chen W; Fan T; Zhang L; Shen B; Zhang Q
Commun Biol; 2024 Mar; 7(1):300. PubMed ID: 38461326
[TBL] [Abstract][Full Text] [Related]
16. The Nitro Group Reshapes the Effects of Pyrido[3,4-
Borisevich SS; Aksinina TE; Ilyina MG; Shender VO; Anufrieva KS; Arapidi GP; Antipova NV; Anizon F; Esvan YJ; Giraud F; Tatarskiy VV; Moreau P; Shakhparonov MI; Pavlyukov MS; Shtil AA
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398225
[TBL] [Abstract][Full Text] [Related]
17. Systems biology approach to identify biomarkers and therapeutic targets for colorectal cancer.
Sadat Kalaki N; Ahmadzadeh M; Najafi M; Mobasheri M; Ajdarkosh H; Karbalaie Niya MH
Biochem Biophys Rep; 2024 Mar; 37():101633. PubMed ID: 38283191
[TBL] [Abstract][Full Text] [Related]
18. DYRK1A suppression attenuates HIF‑1α accumulation and enhances the anti‑liver cancer effects of regorafenib and sorafenib under hypoxic conditions.
Zhang C; Wu LW; Li ZD; Zhang MM; Wu J; Du FH; Zeng LH; Li YL
Int J Oncol; 2022 Apr; 60(4):. PubMed ID: 35244188
[TBL] [Abstract][Full Text] [Related]
19. Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells.
Chen ZY; Li J; Zhu SD; Li ZD; Yu JL; Wu J; Zhang C; Zeng LH
Exp Ther Med; 2022 Mar; 23(3):209. PubMed ID: 35126712
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
